Skip to main content

Evaluation of haemoglobin A1c measurement by an enzymatic method using an automated analyser that has an on-board haemolysis system.

Matsumoto H, Uchino M, Kato M

Publication: Ann Clin Biochem (2013) • Vol 50 • Page 443-9PMID: 23897101View on PubMed

Purpose

The purpose of this paper was to determine the effects of sampling location within the erythrocyte pack and quantification method on levels of glycated hemoglobin (HbA1C) in blood.

Conclusion

Regardless of sampling location relative to the bottom of the tube, measured levels of HbA1C were comparable when measured by the enzymatic assay based Bio Majesty (BM)6010/C or the high-performance liquid-chromatography (HPLC) based Tosoh G7. The authors report no effect of exogenous acetylated hemoglobin (Hb), carbamylated Hb or labile HbA1c on measurement of HbA1c. Levels of HbA1c measured by the BM6010/C were very strongly correlated with those measured by the Primus HPLC and Tosoh G7 HPLC, but a bias of 0.6-3.3% was observed using the BM6010/C.

Studies (1)

Purpose

The purpose of this study was to determine the effects of sampling location within the erythrocyte pack and measurement method on levels of HbA1C in blood from inpatients, outpatients and hospital employees.

Summary of Findings

Regardless of sampling location relative to the bottom of the tube, measured levels of HbA1C were comparable when by the enzymatic assay based BM6010/C and the HPLC based Tosoh G7. The authors report no effect of exogenous acetylated Hb, carbamylated Hb and labile HbA1c on measurement of HbA1c. Levels of HbA1c measured by the BM6010/C were very strongly correlated with those measured by the Primus HPLC (r2=0.997) and Tosoh G7 HPLC (r=0.994), but a bias of 0.6-3.3% was observed using the BM6010/C.

  • Biospecimens

    CellRed Blood Cells
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Not specified
  • Platforms

    ProteinClinical chemistry/auto analyzer
    ProteinHPLC
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    0-10 g/L labile HbA1c added
    0-500 mg/L acetylated Hb added
    0-500 mg/L carbamylated Hb added
    1 mm from bottom
    3 mm from bottom
    5 mm from bottom
    Biospecimen Aliquots and ComponentsBlood and blood products
    Multiple sampling positions examined
    Clinical chemistry/auto analyzer SpecificTechnology platform
    BM6010/C
    Primus HPLC
    Tosoh G7 HPLC